nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—Bupranolol—Carteolol—glaucoma	0.214	0.351	CrCrCtD
Gemfibrozil—Bupranolol—Levobunolol—glaucoma	0.214	0.351	CrCrCtD
Gemfibrozil—Bupranolol—Timolol—glaucoma	0.182	0.298	CrCrCtD
Gemfibrozil—CYP1A2—Betaxolol—glaucoma	0.0308	0.128	CbGbCtD
Gemfibrozil—CYP2C19—Methazolamide—glaucoma	0.0253	0.105	CbGbCtD
Gemfibrozil—CYP2C9—Diclofenamide—glaucoma	0.0245	0.102	CbGbCtD
Gemfibrozil—CYP2C9—Dorzolamide—glaucoma	0.0236	0.0981	CbGbCtD
Gemfibrozil—CYP2C19—Timolol—glaucoma	0.0215	0.0895	CbGbCtD
Gemfibrozil—CYP2C9—Methazolamide—glaucoma	0.0211	0.0875	CbGbCtD
Gemfibrozil—CYP3A4—Pilocarpine—glaucoma	0.0181	0.0753	CbGbCtD
Gemfibrozil—CYP1A2—Clonidine—glaucoma	0.0169	0.0702	CbGbCtD
Gemfibrozil—CYP3A4—Brinzolamide—glaucoma	0.0142	0.0591	CbGbCtD
Gemfibrozil—CYP3A4—Dorzolamide—glaucoma	0.0137	0.0571	CbGbCtD
Gemfibrozil—CYP3A4—Methazolamide—glaucoma	0.0122	0.0509	CbGbCtD
Gemfibrozil—CYP3A4—Acetazolamide—glaucoma	0.00979	0.0407	CbGbCtD
Gemfibrozil—CYP3A4—Clonidine—glaucoma	0.00885	0.0368	CbGbCtD
Gemfibrozil—Dyspepsia—Acetazolamide—glaucoma	0.000174	0.00133	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Clonidine—glaucoma	0.000173	0.00132	CcSEcCtD
Gemfibrozil—Headache—Latanoprost—glaucoma	0.000173	0.00132	CcSEcCtD
Gemfibrozil—Skin disorder—Brinzolamide—glaucoma	0.000173	0.00132	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000173	0.00132	CcSEcCtD
Gemfibrozil—Confusional state—Pilocarpine—glaucoma	0.000173	0.00132	CcSEcCtD
Gemfibrozil—Oedema—Pilocarpine—glaucoma	0.000171	0.00131	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000171	0.0013	CcSEcCtD
Gemfibrozil—Fatigue—Acetazolamide—glaucoma	0.00017	0.0013	CcSEcCtD
Gemfibrozil—Paraesthesia—Brimonidine—glaucoma	0.00017	0.0013	CcSEcCtD
Gemfibrozil—Alopecia—Clonidine—glaucoma	0.00017	0.0013	CcSEcCtD
Gemfibrozil—Nausea—Methazolamide—glaucoma	0.00017	0.0013	CcSEcCtD
Gemfibrozil—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000169	0.00974	CbGpPWpGaD
Gemfibrozil—Somnolence—Brimonidine—glaucoma	0.000169	0.00129	CcSEcCtD
Gemfibrozil—Mental disorder—Clonidine—glaucoma	0.000169	0.00129	CcSEcCtD
Gemfibrozil—Shock—Pilocarpine—glaucoma	0.000168	0.00129	CcSEcCtD
Gemfibrozil—Rhinitis—Betaxolol—glaucoma	0.000168	0.00128	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Pilocarpine—glaucoma	0.000168	0.00128	CcSEcCtD
Gemfibrozil—Dyspepsia—Brimonidine—glaucoma	0.000167	0.00128	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Betaxolol—glaucoma	0.000167	0.00127	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000165	0.00126	CcSEcCtD
Gemfibrozil—Tension—Clonidine—glaucoma	0.000164	0.00126	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Travoprost—glaucoma	0.000164	0.00125	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Brimonidine—glaucoma	0.000164	0.00125	CcSEcCtD
Gemfibrozil—Fatigue—Brimonidine—glaucoma	0.000164	0.00125	CcSEcCtD
Gemfibrozil—Feeling abnormal—Acetazolamide—glaucoma	0.000163	0.00124	CcSEcCtD
Gemfibrozil—Nervousness—Clonidine—glaucoma	0.000163	0.00124	CcSEcCtD
Gemfibrozil—Paraesthesia—Dorzolamide—glaucoma	0.000163	0.00124	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000162	0.00124	CcSEcCtD
Gemfibrozil—Pain—Brimonidine—glaucoma	0.000162	0.00124	CcSEcCtD
Gemfibrozil—Somnolence—Dorzolamide—glaucoma	0.000161	0.00123	CcSEcCtD
Gemfibrozil—Paraesthesia—Brinzolamide—glaucoma	0.00016	0.00122	CcSEcCtD
Gemfibrozil—Dyspepsia—Dorzolamide—glaucoma	0.000159	0.00122	CcSEcCtD
Gemfibrozil—Dyspepsia—Travoprost—glaucoma	0.000159	0.00121	CcSEcCtD
Gemfibrozil—Asthenia—Apraclonidine—glaucoma	0.000159	0.00121	CcSEcCtD
Gemfibrozil—Somnolence—Brinzolamide—glaucoma	0.000158	0.00121	CcSEcCtD
Gemfibrozil—Vision blurred—Clonidine—glaucoma	0.000158	0.00121	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Timolol—glaucoma	0.000157	0.0012	CcSEcCtD
Gemfibrozil—Urticaria—Acetazolamide—glaucoma	0.000157	0.0012	CcSEcCtD
Gemfibrozil—Dyspepsia—Brinzolamide—glaucoma	0.000157	0.0012	CcSEcCtD
Gemfibrozil—Eye disorder—Betaxolol—glaucoma	0.000157	0.0012	CcSEcCtD
Gemfibrozil—Pruritus—Apraclonidine—glaucoma	0.000156	0.00119	CcSEcCtD
Gemfibrozil—Fatigue—Dorzolamide—glaucoma	0.000156	0.00119	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000156	0.00119	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Travoprost—glaucoma	0.000156	0.00119	CcSEcCtD
Gemfibrozil—Fatigue—Travoprost—glaucoma	0.000155	0.00119	CcSEcCtD
Gemfibrozil—PPARA—PPARA activates gene expression—ABCA1—glaucoma	0.000155	0.00895	CbGpPWpGaD
Gemfibrozil—Pain—Dorzolamide—glaucoma	0.000155	0.00118	CcSEcCtD
Gemfibrozil—Weight decreased—Timolol—glaucoma	0.000155	0.00118	CcSEcCtD
Gemfibrozil—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000154	0.00888	CbGpPWpGaD
Gemfibrozil—Pain—Travoprost—glaucoma	0.000154	0.00118	CcSEcCtD
Gemfibrozil—Constipation—Travoprost—glaucoma	0.000154	0.00118	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000154	0.00117	CcSEcCtD
Gemfibrozil—Paraesthesia—Pilocarpine—glaucoma	0.000154	0.00117	CcSEcCtD
Gemfibrozil—Asthenia—Bimatoprost—glaucoma	0.000154	0.00117	CcSEcCtD
Gemfibrozil—Fatigue—Brinzolamide—glaucoma	0.000154	0.00117	CcSEcCtD
Gemfibrozil—Angioedema—Clonidine—glaucoma	0.000153	0.00117	CcSEcCtD
Gemfibrozil—Pain—Brinzolamide—glaucoma	0.000152	0.00116	CcSEcCtD
Gemfibrozil—Somnolence—Pilocarpine—glaucoma	0.000152	0.00116	CcSEcCtD
Gemfibrozil—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000152	0.00876	CbGpPWpGaD
Gemfibrozil—Depression—Timolol—glaucoma	0.000152	0.00116	CcSEcCtD
Gemfibrozil—Pruritus—Bimatoprost—glaucoma	0.000152	0.00116	CcSEcCtD
Gemfibrozil—Diarrhoea—Apraclonidine—glaucoma	0.000151	0.00115	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Betaxolol—glaucoma	0.000151	0.00115	CcSEcCtD
Gemfibrozil—Dyspepsia—Pilocarpine—glaucoma	0.000151	0.00115	CcSEcCtD
Gemfibrozil—Syncope—Clonidine—glaucoma	0.00015	0.00115	CcSEcCtD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00015	0.00863	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Dorzolamide—glaucoma	0.000149	0.00114	CcSEcCtD
Gemfibrozil—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000149	0.00859	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Travoprost—glaucoma	0.000149	0.00114	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dorzolamide—glaucoma	0.000148	0.00113	CcSEcCtD
Gemfibrozil—Alopecia—Betaxolol—glaucoma	0.000148	0.00113	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000148	0.00113	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Travoprost—glaucoma	0.000147	0.00113	CcSEcCtD
Gemfibrozil—Loss of consciousness—Clonidine—glaucoma	0.000147	0.00112	CcSEcCtD
Gemfibrozil—Feeling abnormal—Brinzolamide—glaucoma	0.000147	0.00112	CcSEcCtD
Gemfibrozil—Mental disorder—Betaxolol—glaucoma	0.000147	0.00112	CcSEcCtD
Gemfibrozil—Pain—Pilocarpine—glaucoma	0.000146	0.00112	CcSEcCtD
Gemfibrozil—Constipation—Pilocarpine—glaucoma	0.000146	0.00112	CcSEcCtD
Gemfibrozil—Cough—Clonidine—glaucoma	0.000146	0.00112	CcSEcCtD
Gemfibrozil—Dizziness—Apraclonidine—glaucoma	0.000146	0.00112	CcSEcCtD
Gemfibrozil—Urticaria—Dorzolamide—glaucoma	0.000144	0.0011	CcSEcCtD
Gemfibrozil—Abdominal pain—Dorzolamide—glaucoma	0.000143	0.00109	CcSEcCtD
Gemfibrozil—Tension—Betaxolol—glaucoma	0.000143	0.00109	CcSEcCtD
Gemfibrozil—Dysgeusia—Betaxolol—glaucoma	0.000143	0.00109	CcSEcCtD
Gemfibrozil—Arthralgia—Clonidine—glaucoma	0.000143	0.00109	CcSEcCtD
Gemfibrozil—Chest pain—Clonidine—glaucoma	0.000143	0.00109	CcSEcCtD
Gemfibrozil—Abdominal pain—Travoprost—glaucoma	0.000143	0.00109	CcSEcCtD
Gemfibrozil—Asthenia—Acetazolamide—glaucoma	0.000142	0.00108	CcSEcCtD
Gemfibrozil—Dizziness—Bimatoprost—glaucoma	0.000142	0.00108	CcSEcCtD
Gemfibrozil—Nervousness—Betaxolol—glaucoma	0.000142	0.00108	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000142	0.00108	CcSEcCtD
Gemfibrozil—Urticaria—Brinzolamide—glaucoma	0.000141	0.00108	CcSEcCtD
Gemfibrozil—Feeling abnormal—Pilocarpine—glaucoma	0.000141	0.00108	CcSEcCtD
Gemfibrozil—Vomiting—Apraclonidine—glaucoma	0.00014	0.00107	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Pilocarpine—glaucoma	0.00014	0.00107	CcSEcCtD
Gemfibrozil—Dermatitis—Apraclonidine—glaucoma	0.000139	0.00106	CcSEcCtD
Gemfibrozil—Headache—Apraclonidine—glaucoma	0.000138	0.00106	CcSEcCtD
Gemfibrozil—Confusional state—Clonidine—glaucoma	0.000138	0.00105	CcSEcCtD
Gemfibrozil—Vision blurred—Betaxolol—glaucoma	0.000137	0.00105	CcSEcCtD
Gemfibrozil—Rhinitis—Timolol—glaucoma	0.000137	0.00105	CcSEcCtD
Gemfibrozil—Oedema—Clonidine—glaucoma	0.000137	0.00104	CcSEcCtD
Gemfibrozil—Asthenia—Brimonidine—glaucoma	0.000136	0.00104	CcSEcCtD
Gemfibrozil—Abdominal pain—Pilocarpine—glaucoma	0.000135	0.00103	CcSEcCtD
Gemfibrozil—Diarrhoea—Acetazolamide—glaucoma	0.000135	0.00103	CcSEcCtD
Gemfibrozil—Rash—Bimatoprost—glaucoma	0.000135	0.00103	CcSEcCtD
Gemfibrozil—Dermatitis—Bimatoprost—glaucoma	0.000135	0.00103	CcSEcCtD
Gemfibrozil—Anaemia—Betaxolol—glaucoma	0.000135	0.00103	CcSEcCtD
Gemfibrozil—Shock—Clonidine—glaucoma	0.000134	0.00103	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Timolol—glaucoma	0.000134	0.00103	CcSEcCtD
Gemfibrozil—Pruritus—Brimonidine—glaucoma	0.000134	0.00102	CcSEcCtD
Gemfibrozil—Headache—Bimatoprost—glaucoma	0.000134	0.00102	CcSEcCtD
Gemfibrozil—Nervous system disorder—Clonidine—glaucoma	0.000134	0.00102	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Clonidine—glaucoma	0.000134	0.00102	CcSEcCtD
Gemfibrozil—Skin disorder—Clonidine—glaucoma	0.000133	0.00101	CcSEcCtD
Gemfibrozil—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000132	0.00759	CbGpPWpGaD
Gemfibrozil—Nausea—Apraclonidine—glaucoma	0.000131	0.001	CcSEcCtD
Gemfibrozil—Vertigo—Betaxolol—glaucoma	0.000131	0.001	CcSEcCtD
Gemfibrozil—Syncope—Betaxolol—glaucoma	0.000131	0.000999	CcSEcCtD
Gemfibrozil—Dizziness—Acetazolamide—glaucoma	0.000131	0.000998	CcSEcCtD
Gemfibrozil—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000131	0.00752	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00013	0.0075	CbGpPWpGaD
Gemfibrozil—Asthenia—Dorzolamide—glaucoma	0.00013	0.000992	CcSEcCtD
Gemfibrozil—Asthenia—Travoprost—glaucoma	0.000129	0.000988	CcSEcCtD
Gemfibrozil—Pruritus—Dorzolamide—glaucoma	0.000128	0.000979	CcSEcCtD
Gemfibrozil—Loss of consciousness—Betaxolol—glaucoma	0.000128	0.000979	CcSEcCtD
Gemfibrozil—Eye disorder—Timolol—glaucoma	0.000128	0.000977	CcSEcCtD
Gemfibrozil—Asthenia—Brinzolamide—glaucoma	0.000128	0.000976	CcSEcCtD
Gemfibrozil—Pruritus—Travoprost—glaucoma	0.000128	0.000974	CcSEcCtD
Gemfibrozil—Cough—Betaxolol—glaucoma	0.000127	0.000972	CcSEcCtD
Gemfibrozil—Nausea—Bimatoprost—glaucoma	0.000127	0.000972	CcSEcCtD
Gemfibrozil—Pruritus—Brinzolamide—glaucoma	0.000126	0.000962	CcSEcCtD
Gemfibrozil—Vomiting—Acetazolamide—glaucoma	0.000126	0.00096	CcSEcCtD
Gemfibrozil—Dizziness—Brimonidine—glaucoma	0.000125	0.000958	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Clonidine—glaucoma	0.000125	0.000951	CcSEcCtD
Gemfibrozil—Myalgia—Betaxolol—glaucoma	0.000124	0.000948	CcSEcCtD
Gemfibrozil—Chest pain—Betaxolol—glaucoma	0.000124	0.000948	CcSEcCtD
Gemfibrozil—Arthralgia—Betaxolol—glaucoma	0.000124	0.000948	CcSEcCtD
Gemfibrozil—Diarrhoea—Dorzolamide—glaucoma	0.000124	0.000946	CcSEcCtD
Gemfibrozil—Headache—Acetazolamide—glaucoma	0.000124	0.000945	CcSEcCtD
Gemfibrozil—Diarrhoea—Travoprost—glaucoma	0.000123	0.000942	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Timolol—glaucoma	0.000123	0.000942	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000123	0.000941	CcSEcCtD
Gemfibrozil—Asthenia—Pilocarpine—glaucoma	0.000123	0.000938	CcSEcCtD
Gemfibrozil—Paraesthesia—Clonidine—glaucoma	0.000123	0.000937	CcSEcCtD
Gemfibrozil—Diarrhoea—Brinzolamide—glaucoma	0.000122	0.000931	CcSEcCtD
Gemfibrozil—Somnolence—Clonidine—glaucoma	0.000122	0.000928	CcSEcCtD
Gemfibrozil—Pruritus—Pilocarpine—glaucoma	0.000121	0.000925	CcSEcCtD
Gemfibrozil—Alopecia—Timolol—glaucoma	0.000121	0.000923	CcSEcCtD
Gemfibrozil—Confusional state—Betaxolol—glaucoma	0.00012	0.000916	CcSEcCtD
Gemfibrozil—Mental disorder—Timolol—glaucoma	0.00012	0.000915	CcSEcCtD
Gemfibrozil—Dizziness—Dorzolamide—glaucoma	0.00012	0.000915	CcSEcCtD
Gemfibrozil—Rash—Brimonidine—glaucoma	0.00012	0.000913	CcSEcCtD
Gemfibrozil—Dermatitis—Brimonidine—glaucoma	0.000119	0.000912	CcSEcCtD
Gemfibrozil—Dizziness—Travoprost—glaucoma	0.000119	0.000911	CcSEcCtD
Gemfibrozil—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000119	0.00686	CbGpPWpGaD
Gemfibrozil—Oedema—Betaxolol—glaucoma	0.000119	0.000909	CcSEcCtD
Gemfibrozil—Headache—Brimonidine—glaucoma	0.000119	0.000907	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Clonidine—glaucoma	0.000118	0.000901	CcSEcCtD
Gemfibrozil—Fatigue—Clonidine—glaucoma	0.000118	0.0009	CcSEcCtD
Gemfibrozil—Dizziness—Brinzolamide—glaucoma	0.000118	0.000899	CcSEcCtD
Gemfibrozil—Nausea—Acetazolamide—glaucoma	0.000117	0.000896	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000117	0.00675	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Pilocarpine—glaucoma	0.000117	0.000894	CcSEcCtD
Gemfibrozil—Shock—Betaxolol—glaucoma	0.000117	0.000894	CcSEcCtD
Gemfibrozil—Tension—Timolol—glaucoma	0.000117	0.000893	CcSEcCtD
Gemfibrozil—Constipation—Clonidine—glaucoma	0.000117	0.000893	CcSEcCtD
Gemfibrozil—Pain—Clonidine—glaucoma	0.000117	0.000893	CcSEcCtD
Gemfibrozil—Nervous system disorder—Betaxolol—glaucoma	0.000117	0.000891	CcSEcCtD
Gemfibrozil—Dysgeusia—Timolol—glaucoma	0.000117	0.000891	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Betaxolol—glaucoma	0.000117	0.00089	CcSEcCtD
Gemfibrozil—Nervousness—Timolol—glaucoma	0.000116	0.000884	CcSEcCtD
Gemfibrozil—Skin disorder—Betaxolol—glaucoma	0.000116	0.000883	CcSEcCtD
Gemfibrozil—Vomiting—Dorzolamide—glaucoma	0.000115	0.00088	CcSEcCtD
Gemfibrozil—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000115	0.00663	CbGpPWpGaD
Gemfibrozil—Rash—Dorzolamide—glaucoma	0.000114	0.000872	CcSEcCtD
Gemfibrozil—Dermatitis—Dorzolamide—glaucoma	0.000114	0.000871	CcSEcCtD
Gemfibrozil—Rash—Travoprost—glaucoma	0.000114	0.000868	CcSEcCtD
Gemfibrozil—Dermatitis—Travoprost—glaucoma	0.000114	0.000868	CcSEcCtD
Gemfibrozil—Headache—Dorzolamide—glaucoma	0.000113	0.000867	CcSEcCtD
Gemfibrozil—Vomiting—Brinzolamide—glaucoma	0.000113	0.000865	CcSEcCtD
Gemfibrozil—Dizziness—Pilocarpine—glaucoma	0.000113	0.000864	CcSEcCtD
Gemfibrozil—Headache—Travoprost—glaucoma	0.000113	0.000863	CcSEcCtD
Gemfibrozil—Nausea—Brimonidine—glaucoma	0.000113	0.00086	CcSEcCtD
Gemfibrozil—Feeling abnormal—Clonidine—glaucoma	0.000113	0.00086	CcSEcCtD
Gemfibrozil—Rash—Brinzolamide—glaucoma	0.000112	0.000857	CcSEcCtD
Gemfibrozil—Vision blurred—Timolol—glaucoma	0.000112	0.000857	CcSEcCtD
Gemfibrozil—Dermatitis—Brinzolamide—glaucoma	0.000112	0.000857	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Clonidine—glaucoma	0.000112	0.000854	CcSEcCtD
Gemfibrozil—Headache—Brinzolamide—glaucoma	0.000112	0.000852	CcSEcCtD
Gemfibrozil—Angioedema—Timolol—glaucoma	0.000109	0.000831	CcSEcCtD
Gemfibrozil—Vomiting—Pilocarpine—glaucoma	0.000109	0.000831	CcSEcCtD
Gemfibrozil—Urticaria—Clonidine—glaucoma	0.000109	0.000829	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000108	0.000828	CcSEcCtD
Gemfibrozil—Abdominal pain—Clonidine—glaucoma	0.000108	0.000825	CcSEcCtD
Gemfibrozil—Rash—Pilocarpine—glaucoma	0.000108	0.000824	CcSEcCtD
Gemfibrozil—Dermatitis—Pilocarpine—glaucoma	0.000108	0.000823	CcSEcCtD
Gemfibrozil—Nausea—Dorzolamide—glaucoma	0.000108	0.000822	CcSEcCtD
Gemfibrozil—Headache—Pilocarpine—glaucoma	0.000107	0.000819	CcSEcCtD
Gemfibrozil—Nausea—Travoprost—glaucoma	0.000107	0.000818	CcSEcCtD
Gemfibrozil—Vertigo—Timolol—glaucoma	0.000107	0.000817	CcSEcCtD
Gemfibrozil—Paraesthesia—Betaxolol—glaucoma	0.000107	0.000816	CcSEcCtD
Gemfibrozil—Syncope—Timolol—glaucoma	0.000107	0.000816	CcSEcCtD
Gemfibrozil—Nausea—Brinzolamide—glaucoma	0.000106	0.000808	CcSEcCtD
Gemfibrozil—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000106	0.00609	CbGpPWpGaD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000105	0.00604	CbGpPWpGaD
Gemfibrozil—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000105	0.00603	CbGpPWpGaD
Gemfibrozil—Dyspepsia—Betaxolol—glaucoma	0.000105	0.0008	CcSEcCtD
Gemfibrozil—Loss of consciousness—Timolol—glaucoma	0.000105	0.0008	CcSEcCtD
Gemfibrozil—Cough—Timolol—glaucoma	0.000104	0.000794	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Betaxolol—glaucoma	0.000103	0.000785	CcSEcCtD
Gemfibrozil—Fatigue—Betaxolol—glaucoma	0.000103	0.000784	CcSEcCtD
Gemfibrozil—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000102	0.00586	CbGpPWpGaD
Gemfibrozil—Constipation—Betaxolol—glaucoma	0.000102	0.000777	CcSEcCtD
Gemfibrozil—Pain—Betaxolol—glaucoma	0.000102	0.000777	CcSEcCtD
Gemfibrozil—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000102	0.00586	CbGpPWpGaD
Gemfibrozil—Nausea—Pilocarpine—glaucoma	0.000102	0.000776	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000102	0.00585	CbGpPWpGaD
Gemfibrozil—Chest pain—Timolol—glaucoma	0.000101	0.000774	CcSEcCtD
Gemfibrozil—Myalgia—Timolol—glaucoma	0.000101	0.000774	CcSEcCtD
Gemfibrozil—Arthralgia—Timolol—glaucoma	0.000101	0.000774	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000101	0.000769	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—NR3C1—glaucoma	0.000101	0.00579	CbGpPWpGaD
Gemfibrozil—Asthenia—Clonidine—glaucoma	9.81e-05	0.000749	CcSEcCtD
Gemfibrozil—Feeling abnormal—Betaxolol—glaucoma	9.81e-05	0.000749	CcSEcCtD
Gemfibrozil—Confusional state—Timolol—glaucoma	9.8e-05	0.000749	CcSEcCtD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—PEX19—glaucoma	9.79e-05	0.00564	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—FAS—glaucoma	9.74e-05	0.00561	CbGpPWpGaD
Gemfibrozil—Oedema—Timolol—glaucoma	9.72e-05	0.000742	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Timolol—glaucoma	9.72e-05	0.000742	CcSEcCtD
Gemfibrozil—Pruritus—Clonidine—glaucoma	9.67e-05	0.000739	CcSEcCtD
Gemfibrozil—Shock—Timolol—glaucoma	9.56e-05	0.00073	CcSEcCtD
Gemfibrozil—PPARA—Metabolism—NARFL—glaucoma	9.56e-05	0.0055	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CA5A—glaucoma	9.56e-05	0.0055	CbGpPWpGaD
Gemfibrozil—Nervous system disorder—Timolol—glaucoma	9.53e-05	0.000728	CcSEcCtD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	9.47e-05	0.00545	CbGpPWpGaD
Gemfibrozil—Urticaria—Betaxolol—glaucoma	9.45e-05	0.000722	CcSEcCtD
Gemfibrozil—Skin disorder—Timolol—glaucoma	9.44e-05	0.000721	CcSEcCtD
Gemfibrozil—Diarrhoea—Clonidine—glaucoma	9.35e-05	0.000714	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—NGFR—glaucoma	9.24e-05	0.00532	CbGpPWpGaD
Gemfibrozil—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	9.2e-05	0.0053	CbGpPWpGaD
Gemfibrozil—Dizziness—Clonidine—glaucoma	9.04e-05	0.00069	CcSEcCtD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.97e-05	0.00516	CbGpPWpGaD
Gemfibrozil—Musculoskeletal discomfort—Timolol—glaucoma	8.86e-05	0.000676	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—NTRK1—glaucoma	8.77e-05	0.00505	CbGpPWpGaD
Gemfibrozil—Paraesthesia—Timolol—glaucoma	8.73e-05	0.000667	CcSEcCtD
Gemfibrozil—Vomiting—Clonidine—glaucoma	8.69e-05	0.000664	CcSEcCtD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	8.69e-05	0.005	CbGpPWpGaD
Gemfibrozil—Somnolence—Timolol—glaucoma	8.64e-05	0.00066	CcSEcCtD
Gemfibrozil—Rash—Clonidine—glaucoma	8.62e-05	0.000658	CcSEcCtD
Gemfibrozil—PPARA—Developmental Biology—NCK2—glaucoma	8.62e-05	0.00496	CbGpPWpGaD
Gemfibrozil—Dermatitis—Clonidine—glaucoma	8.61e-05	0.000658	CcSEcCtD
Gemfibrozil—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	8.6e-05	0.00495	CbGpPWpGaD
Gemfibrozil—Headache—Clonidine—glaucoma	8.56e-05	0.000654	CcSEcCtD
Gemfibrozil—Dyspepsia—Timolol—glaucoma	8.56e-05	0.000654	CcSEcCtD
Gemfibrozil—Asthenia—Betaxolol—glaucoma	8.54e-05	0.000652	CcSEcCtD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	8.45e-05	0.00487	CbGpPWpGaD
Gemfibrozil—Pruritus—Betaxolol—glaucoma	8.42e-05	0.000643	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Timolol—glaucoma	8.39e-05	0.000641	CcSEcCtD
Gemfibrozil—Fatigue—Timolol—glaucoma	8.38e-05	0.00064	CcSEcCtD
Gemfibrozil—Pain—Timolol—glaucoma	8.31e-05	0.000635	CcSEcCtD
Gemfibrozil—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	8.23e-05	0.00474	CbGpPWpGaD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.18e-05	0.00471	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Betaxolol—glaucoma	8.14e-05	0.000622	CcSEcCtD
Gemfibrozil—Nausea—Clonidine—glaucoma	8.12e-05	0.00062	CcSEcCtD
Gemfibrozil—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.08e-05	0.00465	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Timolol—glaucoma	8.01e-05	0.000612	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Timolol—glaucoma	7.95e-05	0.000607	CcSEcCtD
Gemfibrozil—Dizziness—Betaxolol—glaucoma	7.87e-05	0.000601	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.82e-05	0.0045	CbGpPWpGaD
Gemfibrozil—Urticaria—Timolol—glaucoma	7.72e-05	0.00059	CcSEcCtD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	7.71e-05	0.00444	CbGpPWpGaD
Gemfibrozil—Abdominal pain—Timolol—glaucoma	7.69e-05	0.000587	CcSEcCtD
Gemfibrozil—Vomiting—Betaxolol—glaucoma	7.57e-05	0.000578	CcSEcCtD
Gemfibrozil—Rash—Betaxolol—glaucoma	7.5e-05	0.000573	CcSEcCtD
Gemfibrozil—Dermatitis—Betaxolol—glaucoma	7.5e-05	0.000572	CcSEcCtD
Gemfibrozil—Headache—Betaxolol—glaucoma	7.45e-05	0.000569	CcSEcCtD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.3e-05	0.00421	CbGpPWpGaD
Gemfibrozil—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.21e-05	0.00415	CbGpPWpGaD
Gemfibrozil—Nausea—Betaxolol—glaucoma	7.07e-05	0.00054	CcSEcCtD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	7.04e-05	0.00405	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	7.04e-05	0.00405	CbGpPWpGaD
Gemfibrozil—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	7.04e-05	0.00405	CbGpPWpGaD
Gemfibrozil—Asthenia—Timolol—glaucoma	6.98e-05	0.000533	CcSEcCtD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	6.92e-05	0.00398	CbGpPWpGaD
Gemfibrozil—Pruritus—Timolol—glaucoma	6.88e-05	0.000525	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—FAS—glaucoma	6.88e-05	0.00396	CbGpPWpGaD
Gemfibrozil—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	6.7e-05	0.00386	CbGpPWpGaD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.66e-05	0.00384	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Timolol—glaucoma	6.65e-05	0.000508	CcSEcCtD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.63e-05	0.00382	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	6.62e-05	0.00381	CbGpPWpGaD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	6.59e-05	0.00379	CbGpPWpGaD
Gemfibrozil—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.57e-05	0.00378	CbGpPWpGaD
Gemfibrozil—Dizziness—Timolol—glaucoma	6.43e-05	0.000491	CcSEcCtD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	6.36e-05	0.00366	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	6.29e-05	0.00362	CbGpPWpGaD
Gemfibrozil—Vomiting—Timolol—glaucoma	6.18e-05	0.000472	CcSEcCtD
Gemfibrozil—Rash—Timolol—glaucoma	6.13e-05	0.000468	CcSEcCtD
Gemfibrozil—Dermatitis—Timolol—glaucoma	6.12e-05	0.000468	CcSEcCtD
Gemfibrozil—Headache—Timolol—glaucoma	6.09e-05	0.000465	CcSEcCtD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.92e-05	0.00341	CbGpPWpGaD
Gemfibrozil—Nausea—Timolol—glaucoma	5.77e-05	0.000441	CcSEcCtD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.73e-05	0.0033	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.72e-05	0.0033	CbGpPWpGaD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.69e-05	0.00328	CbGpPWpGaD
Gemfibrozil—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.62e-05	0.00323	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—PAX6—glaucoma	5.58e-05	0.00321	CbGpPWpGaD
Gemfibrozil—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	5.43e-05	0.00313	CbGpPWpGaD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.4e-05	0.00311	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CA5A—glaucoma	5.39e-05	0.00311	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NARFL—glaucoma	5.39e-05	0.00311	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase II conjugation—GSTT1—glaucoma	5.26e-05	0.00303	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CA1—glaucoma	4.67e-05	0.00269	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.61e-05	0.00266	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CTSA—glaucoma	4.52e-05	0.0026	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—GSTT1—glaucoma	4.42e-05	0.00255	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.41e-05	0.00254	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.39e-05	0.00253	CbGpPWpGaD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.33e-05	0.0025	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CA2—glaucoma	4.27e-05	0.00246	CbGpPWpGaD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	4.27e-05	0.00246	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—CDKN2B—glaucoma	4.18e-05	0.00241	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.17e-05	0.0024	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.17e-05	0.0024	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—TNF—glaucoma	4.14e-05	0.00238	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—GSTT1—glaucoma	3.95e-05	0.00227	CbGpPWpGaD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	3.81e-05	0.00219	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—NR3C1—glaucoma	3.67e-05	0.00211	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.6e-05	0.00207	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.56e-05	0.00205	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP1B1—glaucoma	3.52e-05	0.00203	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	3.48e-05	0.002	CbGpPWpGaD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.47e-05	0.002	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase II conjugation—GSTM1—glaucoma	3.35e-05	0.00193	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.29e-05	0.0019	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.23e-05	0.00186	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	3.17e-05	0.00183	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.15e-05	0.00181	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.1e-05	0.00179	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NARFL—glaucoma	3.1e-05	0.00179	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA5A—glaucoma	3.1e-05	0.00179	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTT1—glaucoma	3.08e-05	0.00177	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TXN—glaucoma	3.01e-05	0.00173	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	3e-05	0.00173	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	3e-05	0.00173	CbGpPWpGaD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	2.97e-05	0.00171	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.94e-05	0.00169	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.87e-05	0.00165	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.83e-05	0.00163	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—GSTM1—glaucoma	2.82e-05	0.00162	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	2.78e-05	0.0016	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA5A—glaucoma	2.77e-05	0.00159	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NARFL—glaucoma	2.77e-05	0.00159	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.74e-05	0.00158	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.72e-05	0.00157	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.68e-05	0.00154	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CA1—glaucoma	2.63e-05	0.00152	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—TP53—glaucoma	2.57e-05	0.00148	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CTSA—glaucoma	2.55e-05	0.00147	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NARFL—glaucoma	2.52e-05	0.00145	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA5A—glaucoma	2.52e-05	0.00145	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.51e-05	0.00145	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	2.5e-05	0.00144	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.48e-05	0.00143	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP2—glaucoma	2.46e-05	0.00142	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP1B1—glaucoma	2.45e-05	0.00141	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	2.42e-05	0.00139	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CA2—glaucoma	2.41e-05	0.00139	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.37e-05	0.00137	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.36e-05	0.00136	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.36e-05	0.00136	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTT1—glaucoma	2.33e-05	0.00134	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.29e-05	0.00132	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.29e-05	0.00132	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.26e-05	0.0013	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA5A—glaucoma	2.16e-05	0.00124	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NARFL—glaucoma	2.16e-05	0.00124	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.14e-05	0.00123	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.14e-05	0.00123	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—CDKN2B—glaucoma	2.01e-05	0.00116	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTM1—glaucoma	1.96e-05	0.00113	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	1.93e-05	0.00111	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.89e-05	0.00109	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.88e-05	0.00108	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.87e-05	0.00107	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ABCA1—glaucoma	1.86e-05	0.00107	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP1B1—glaucoma	1.86e-05	0.00107	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP9—glaucoma	1.85e-05	0.00106	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—NR3C1—glaucoma	1.77e-05	0.00102	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TXN—glaucoma	1.7e-05	0.000978	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA5A—glaucoma	1.66e-05	0.000958	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NARFL—glaucoma	1.66e-05	0.000958	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—glaucoma	1.66e-05	0.000955	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.55e-05	0.000892	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.53e-05	0.000884	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA1—glaucoma	1.51e-05	0.000872	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.51e-05	0.000871	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.49e-05	0.000859	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTM1—glaucoma	1.49e-05	0.000856	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CTSA—glaucoma	1.47e-05	0.000844	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TNF—glaucoma	1.42e-05	0.000819	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA2—glaucoma	1.38e-05	0.000797	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.35e-05	0.000779	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.35e-05	0.000779	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA1—glaucoma	1.35e-05	0.000778	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTT1—glaucoma	1.32e-05	0.000758	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—MTHFR—glaucoma	1.31e-05	0.000756	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CTSA—glaucoma	1.31e-05	0.000754	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA2—glaucoma	1.24e-05	0.000712	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA1—glaucoma	1.23e-05	0.000709	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—APOE—glaucoma	1.22e-05	0.000704	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CAV1—glaucoma	1.21e-05	0.000697	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.21e-05	0.000696	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.21e-05	0.000696	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CTSA—glaucoma	1.19e-05	0.000687	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA2—glaucoma	1.13e-05	0.000649	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.1e-05	0.000634	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.1e-05	0.000634	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.06e-05	0.000611	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA1—glaucoma	1.05e-05	0.000606	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1B1—glaucoma	1.05e-05	0.000604	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ABCA1—glaucoma	1.05e-05	0.000604	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CTSA—glaucoma	1.02e-05	0.000587	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TXN—glaucoma	9.76e-06	0.000562	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA2—glaucoma	9.63e-06	0.000554	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.41e-06	0.000542	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.41e-06	0.000542	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—NOS3—glaucoma	9.16e-06	0.000527	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.9e-06	0.000513	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.82e-06	0.000508	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TXN—glaucoma	8.71e-06	0.000501	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTM1—glaucoma	8.38e-06	0.000483	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—glaucoma	8.38e-06	0.000482	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA1—glaucoma	8.13e-06	0.000468	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.94e-06	0.000457	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TXN—glaucoma	7.94e-06	0.000457	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.87e-06	0.000453	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CTSA—glaucoma	7.87e-06	0.000453	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTT1—glaucoma	7.56e-06	0.000436	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA2—glaucoma	7.43e-06	0.000428	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MTHFR—glaucoma	7.41e-06	0.000427	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.24e-06	0.000417	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.18e-06	0.000413	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—APOE—glaucoma	6.9e-06	0.000397	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CAV1—glaucoma	6.84e-06	0.000394	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TXN—glaucoma	6.78e-06	0.000391	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTT1—glaucoma	6.75e-06	0.000389	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.19e-06	0.000356	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—glaucoma	6.16e-06	0.000354	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.13e-06	0.000353	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.1e-06	0.000351	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCA1—glaucoma	6.03e-06	0.000347	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1B1—glaucoma	6.03e-06	0.000347	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.44e-06	0.000313	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCA1—glaucoma	5.38e-06	0.00031	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1B1—glaucoma	5.38e-06	0.00031	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—glaucoma	5.26e-06	0.000303	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TXN—glaucoma	5.24e-06	0.000302	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—glaucoma	5.17e-06	0.000298	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.96e-06	0.000286	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCA1—glaucoma	4.9e-06	0.000282	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1B1—glaucoma	4.9e-06	0.000282	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—glaucoma	4.82e-06	0.000277	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—glaucoma	4.73e-06	0.000272	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—glaucoma	4.3e-06	0.000248	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—glaucoma	4.26e-06	0.000245	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.24e-06	0.000244	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1B1—glaucoma	4.19e-06	0.000241	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCA1—glaucoma	4.19e-06	0.000241	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—glaucoma	4.06e-06	0.000234	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOE—glaucoma	3.96e-06	0.000228	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CAV1—glaucoma	3.93e-06	0.000226	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—glaucoma	3.92e-06	0.000226	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—glaucoma	3.8e-06	0.000219	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOE—glaucoma	3.54e-06	0.000204	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CAV1—glaucoma	3.51e-06	0.000202	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—glaucoma	3.47e-06	0.0002	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—glaucoma	3.35e-06	0.000193	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1B1—glaucoma	3.23e-06	0.000186	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCA1—glaucoma	3.23e-06	0.000186	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOE—glaucoma	3.23e-06	0.000186	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CAV1—glaucoma	3.2e-06	0.000184	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—glaucoma	2.97e-06	0.000171	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—glaucoma	2.96e-06	0.000171	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOE—glaucoma	2.76e-06	0.000159	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CAV1—glaucoma	2.73e-06	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—glaucoma	2.72e-06	0.000156	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—glaucoma	2.65e-06	0.000153	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—glaucoma	2.59e-06	0.000149	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—glaucoma	2.42e-06	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—glaucoma	2.42e-06	0.000139	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—glaucoma	2.29e-06	0.000132	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—glaucoma	2.21e-06	0.000127	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOE—glaucoma	2.13e-06	0.000123	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CAV1—glaucoma	2.11e-06	0.000121	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—glaucoma	2.07e-06	0.000119	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—glaucoma	1.89e-06	0.000109	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—glaucoma	1.59e-06	9.18e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—glaucoma	1.46e-06	8.4e-05	CbGpPWpGaD
